The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

BACKGROUND: The Stop&Go study randomized patients with advanced breast cancer to intermittent (two times four) or continuous (eight subsequent cycles) first- and second-line chemotherapy. METHODS: QoL was measured with RAND-36 questionnaires every 12 weeks. The primary objective was to estimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Claessens, Anouk K. M., Timman, Reinier, Busschbach, Jan J., Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Erdkamp, Frans L. G., Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997247/
https://www.ncbi.nlm.nih.gov/pubmed/31782032
http://dx.doi.org/10.1007/s10549-019-05495-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997247/
https://www.ncbi.nlm.nih.gov/pubmed/31782032
http://dx.doi.org/10.1007/s10549-019-05495-3

Ejemplares similares